MENU
GDOC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

GDOC stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for GDOC with price predictions
Nov 10, 2026

GDOC in upward trend: price rose above 50-day moving average on October 21, 2026

GDOC moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on GDOC as a result. In 71 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for GDOC just turned positive on October 19, 2026. Looking at past instances where GDOC's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.

The 10-day moving average for GDOC crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +5.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where GDOC advanced for three days, in 180 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 223 of 264 cases where GDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 62 cases where GDOC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.

GDOC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Gilead Sciences (NASDAQ:GILD), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Guardant Health (NASDAQ:GH).

Industry description

The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Market Cap

The average market capitalization across the Future Health Care Equity ETF (GDOC) ETF is 103.7B. The market cap for tickers in the group ranges from 1.45B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is KARD at 1.45B.

High and low price notable news

The average weekly price growth across all stocks in the Future Health Care Equity ETF (GDOC) ETF was 22%. For the same ETF, the average monthly price growth was 44%, and the average quarterly price growth was 407%. RYTM experienced the highest price growth at 32%, while NTRA experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Future Health Care Equity ETF (GDOC) ETF was -25%. For the same stocks of the ETF, the average monthly volume growth was -15% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 44
Price Growth Rating: 38
SMR Rating: 65
Profit Risk Rating: 66
Seasonality Score: 23 (-100 ... +100)
GDOC in upward trend: price rose above 50-day moving average on October 21, 2026